106 related articles for article (PubMed ID: 12872613)
1. Preparation and pharmacological evaluation of silibinin liposomes.
Maheshwari H; Agarwal R; Patil C; Katare OP
Arzneimittelforschung; 2003; 53(6):420-7. PubMed ID: 12872613
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of hybrid liposomes-encapsulated silymarin regarding physical stability and in vivo performance.
El-Samaligy MS; Afifi NN; Mahmoud EA
Int J Pharm; 2006 Aug; 319(1-2):121-9. PubMed ID: 16837151
[TBL] [Abstract][Full Text] [Related]
3. Improved in vitro and in vivo hepatoprotective effects of liposomal silymarin in alcohol-induced hepatotoxicity in Wistar rats.
Kumar N; Rai A; Reddy ND; Shenoy RR; Mudgal J; Bansal P; Mudgal PP; Arumugam K; Udupa N; Sharma N; Rao CM
Pharmacol Rep; 2019 Aug; 71(4):703-712. PubMed ID: 31207432
[TBL] [Abstract][Full Text] [Related]
4. Silymarin-Loaded Eudragit Nanoparticles: Formulation, Characterization, and Hepatoprotective and Toxicity Evaluation.
El-Nahas AE; Allam AN; Abdelmonsif DA; El-Kamel AH
AAPS PharmSciTech; 2017 Nov; 18(8):3076-3086. PubMed ID: 28516410
[TBL] [Abstract][Full Text] [Related]
5. Silymarin liposomes improves oral bioavailability of silybin besides targeting hepatocytes, and immune cells.
Kumar N; Rai A; Reddy ND; Raj PV; Jain P; Deshpande P; Mathew G; Kutty NG; Udupa N; Rao CM
Pharmacol Rep; 2014 Oct; 66(5):788-98. PubMed ID: 25149982
[TBL] [Abstract][Full Text] [Related]
6. Isolation of herpetin from Herpetospermum seed and hepatoprotective activity of liposomal herpetin against carbon tetrachloride-induced liver injury in mice.
Gu J; Yuan Z; Tan R; Zhang X
Pharmazie; 2015 Nov; 70(11):745-52. PubMed ID: 26790192
[TBL] [Abstract][Full Text] [Related]
7. Development of vitamin loaded topical liposomal formulation using factorial design approach: drug deposition and stability.
Padamwar MN; Pokharkar VB
Int J Pharm; 2006 Aug; 320(1-2):37-44. PubMed ID: 16707237
[TBL] [Abstract][Full Text] [Related]
8. Comparative study of different silymarin formulations: formulation, characterisation and in vitro/in vivo evaluation.
Abrol S; Trehan A; Katare OP
Curr Drug Deliv; 2005 Jan; 2(1):45-51. PubMed ID: 16305407
[TBL] [Abstract][Full Text] [Related]
9. Tamoxifen in topical liposomes: development, characterization and in-vitro evaluation.
Bhatia A; Kumar R; Katare OP
J Pharm Pharm Sci; 2004 Jul; 7(2):252-9. PubMed ID: 15367383
[TBL] [Abstract][Full Text] [Related]
10. Improved hepatoprotective activity of silymarin via encapsulation in the novel vesicular nanosystem bilosomes.
Mohsen AM; Asfour MH; Salama AAA
Drug Dev Ind Pharm; 2017 Dec; 43(12):2043-2054. PubMed ID: 28756693
[TBL] [Abstract][Full Text] [Related]
11. A New Type of Liquid Silymarin Proliposome Containing Bile Salts: Its Preparation and Improved Hepatoprotective Effects.
Wang M; Xie T; Chang Z; Wang L; Xie X; Kou Y; Xu H; Gao X
PLoS One; 2015; 10(12):e0143625. PubMed ID: 26674103
[TBL] [Abstract][Full Text] [Related]
12. Silymarin, the antioxidant component and Silybum marianum extracts prevent liver damage.
Shaker E; Mahmoud H; Mnaa S
Food Chem Toxicol; 2010 Mar; 48(3):803-6. PubMed ID: 20034535
[TBL] [Abstract][Full Text] [Related]
13. Enhancement of hepatoprotective efficacy of propolis by fabrication of liposomes, as a platform nano-formulation for multi-component natural medicine.
Ambardekar RV; Mahadik KR; Paradkar AR; Harsulkar AM
Curr Drug Deliv; 2012 Sep; 9(5):477-86. PubMed ID: 22920575
[TBL] [Abstract][Full Text] [Related]
14. Oil based nanocarrier for improved oral delivery of silymarin: In vitro and in vivo studies.
Parveen R; Baboota S; Ali J; Ahuja A; Vasudev SS; Ahmad S
Int J Pharm; 2011 Jul; 413(1-2):245-53. PubMed ID: 21549187
[TBL] [Abstract][Full Text] [Related]
15. Increasing bioavailability of silymarin using a buccal liposomal delivery system: preparation and experimental design investigation.
El-Samaligy MS; Afifi NN; Mahmoud EA
Int J Pharm; 2006 Feb; 308(1-2):140-8. PubMed ID: 16356669
[TBL] [Abstract][Full Text] [Related]
16. [Preparation of silymarin proliposomes and its pharmacokinetics in rats].
Xiao YY; Song YM; Chen ZP; Ping QN
Yao Xue Xue Bao; 2005 Aug; 40(8):758-63. PubMed ID: 16268514
[TBL] [Abstract][Full Text] [Related]
17. A novel solid dispersion system for natural product-loaded medicine: silymarin-loaded solid dispersion with enhanced oral bioavailability and hepatoprotective activity.
Hwang du H; Kim YI; Cho KH; Poudel BK; Choi JY; Kim DW; Shin YJ; Bae ON; Yousaf AM; Yong CS; Kim JO; Choi HG
J Microencapsul; 2014; 31(7):619-26. PubMed ID: 24766208
[TBL] [Abstract][Full Text] [Related]
18. Antioxidant and hepatoprotective effects of silymarin phytosomes compared to milk thistle extract in CCl4 induced hepatotoxicity in rats.
El-Gazayerly ON; Makhlouf AI; Soelm AM; Mohmoud MA
J Microencapsul; 2014; 31(1):23-30. PubMed ID: 23808477
[TBL] [Abstract][Full Text] [Related]
19. Enhanced oral bioavailability of silymarin using liposomes containing a bile salt: preparation by supercritical fluid technology and evaluation in vitro and in vivo.
Yang G; Zhao Y; Zhang Y; Dang B; Liu Y; Feng N
Int J Nanomedicine; 2015; 10():6633-44. PubMed ID: 26543366
[TBL] [Abstract][Full Text] [Related]
20. Preparation of silymarin proliposome: a new way to increase oral bioavailability of silymarin in beagle dogs.
Yan-yu X; Yun-mei S; Zhi-peng C; Qi-neng P
Int J Pharm; 2006 Aug; 319(1-2):162-8. PubMed ID: 16687221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
